期刊文献+

血清PCT、CRP水平对脓毒症的诊断及预后评估的价值 被引量:14

Diagnostic and Prognosis-Evaluted Value of Serum Procal Citonin and C-Reactive Protein on Sepsis
下载PDF
导出
摘要 目的探讨血清PCT、CRP水平对脓毒症的诊断及预后评估的价值。方法回顾分析2012年7月-2013年5月入住本院EICU的危重患者120例,其中脓毒症患者63例,非脓毒症患者57例作为对照。脓毒症患者根据预后情况分为生存组和死亡组,分析各组的血清PCT和CRP水平。结果脓毒症组血清PCT和CRP水平以及APACHEⅡ评分和SOFA评分均显著大于非脓毒症组(P〈0.05);血清PCT诊断脓毒症的敏感性、特异性、阳性预测值和阴性预测值均明显大于血清CRP(P〈0.05);生存组的血清PCT和CRP值在第1、3、5、7天均显著地小于死亡组(P〈0.05),并有显著的时间效应(P〈0.05),但在死亡组却无显著的时间效应(P〉0.05)。结论血清PCT和CRP是诊断脓毒症和评估预后的可靠指标,并且血清PCT敏感性和特异性高于血清CRP。 Objective To explore the diagnostic and prognosis-evaluted value of serum procal citonin( PCT) and Creactive protein( CRP) on sepsis. Methods A total of 120 patients in our hospital EICU from July 2012 to May 2013,including 63 cases of sepsis( sepsis group) and 57 cases of cases of non-sepsis( non-sepsis group) were tested the levels of serum PCT and CRP. Sepsis patients were divided into survival group and death group according the prognosis. Results The levels of serum PCT and CRP,as well as acute physiology and chronic health evaluation Ⅱ( APACHEⅡ) scores and sepsis related organ failure assessment( SOFA) scores in the sepsis group were significantly larger than those in the nonsepsis and control groups( P〈 0. 05). The sensitivity,specificity,positive predictive value,and negative predictive value for serum PCT in diagnosing sepsis were significantly larger than those for serum CRP( P〈 0. 05). The levels of serum PCT and CRP in survival group were less than those in death group on the 1,3,5,and 7 days( P〈 0. 05). Moreover,there was significant time effects on level of serum PCT1 and CRP in survival group( P〈 0. 05),but not in death group( P〈 0. 05).Conclusions The levels of serum PCT and CRP are reliability indexes for in diagnosing sepsis and evaluating prognosis. Moreover the sensitivity and specificity of serum PCT were better those of serum CRP
出处 《中南医学科学杂志》 CAS 2015年第1期59-62,共4页 Medical Science Journal of Central South China
关键词 降钙素原 C反应蛋白 脓毒症 预后 PCT CRP Sepsis Prognosis
  • 相关文献

参考文献12

二级参考文献50

  • 1郭建秀,李鹏,伍艳芳,易维京,刘进军,郭鹰,唐捷,胡川闽.抗人MIF单克隆抗体的制备及其活性的初步鉴定[J].第三军医大学学报,2006,28(6):546-549. 被引量:4
  • 2郭杰标,郭锐,刘艳华.以抗体竞争结合抗原测定单抗亲和力常数的研究[J].南方医科大学学报,2006,26(7):1057-1059. 被引量:9
  • 3Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics[J]. Pediatr Crit Care Med, 2005, 6( 1 ) : 2 -8.
  • 4Herzum I, Renz H. Inflammatory markers in SIRS, sepsis and septic shock[J]. Curr Med Chem, 2008, 15(6) : 581 -587.
  • 5Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome[ J]. Clin Chim Acta, 2005, 351(1/2) : 17 -29.
  • 6Rey C, Los-Arcos M, Concha A, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children[J]. Intensive Care Med, 2007, 33(3) : 477 -484.
  • 7Koksal N, Harmanci R, Cetinkaya M, et al. Role of procalcitonin and CRP in diagnosis and follow-up of neonatal sepsis[ J]. Turk J Pediatr, 2007, 49(1) : 21 -29.
  • 8Caldas J P, Marba S T, Blotta M H, et al. Accuracy of white blood cell count, C-reactive protein, interleukin-6 and tumor necrosis factor alpha for diagnosing late neonatal sepsis[ J]. J Pediatr ( Rio-J), 2008, 84(6) : 536 -542.
  • 9Cetinkaya M, Ozkan H, Koksal N, et al. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants [ J ]. J Perinatol, 2009, 29(3) : 225 -231.
  • 10Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:an analysis of incidence,outcome and associated costs of care[J].Crit Care Med,2001,29:1303.

共引文献82

同被引文献158

  • 1罗椿意,李维,刘双全.内质网应激与感染性疾病研究进展[J].中南医学科学杂志,2020,0(2):218-220. 被引量:2
  • 2时兢,宋秀琴,俞亚芬,穆会君.降钙素原和C-反应蛋白对脓毒症的诊断价值比较[J].临床急诊杂志,2004,5(5):7-8. 被引量:3
  • 3刘丹红,徐勇勇.住院患者病情危重度的分类决策树研究[J].数理统计与管理,2005,24(1):121-127. 被引量:7
  • 4Caccialanza R, Palladini G, Klersy C, et al. Serum prealbumin: an in- depeddent marker of short-term energy intake in the presence of multi- pie-organ disease involvement [J]. Nutrition ,2013,29 (3) :580-582.
  • 5De Waele J, Carlier M, Hoste E,et al.Extended versus bo- lus infusion of meropenem and piperacillin :a~pharmaeoki- netie analysis[J].Minerva Anestesiol,2014,80(12) : 1302- 1309.
  • 6Langan KM,Jacob J, Li J,et al.Pharmacokinetics of short versus extended infusion meropenem dosin~ in critically ill patients: a pilot study[J].Crit Care Resusc ,~2014, 16 (3) : 190-196.
  • 7Falagas ME,Tansarli GS,Ikawa K,et al.Clinical outcomes with extended or continuous versus short'term intravenous infusion of carbapenems and piperacillin/tazobactam:a sys- tematic review and meta'analysis[J].Clin InfeCt Dis, 2013, 56(2) : 272-282.
  • 8Dellinger RP,Levy MM,Rhodes A,e t a/Surviving sepsis cam- paign:international guidelines for management of severe sepsis and septic shock :2012[J].Crit Care Med, 2013,41 (2) : 580-637.
  • 9Cutro SR, Holzman R,Dubrovskaya Y,et al.Extended-In-fusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center[J].An- timicrob Agents Chemother,2014,58(8) :4470-4475.
  • 10Eiki K, Junko K, Yasuyuki N,et al.Comparison of the phar- macodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions[J].Antimicrob Agents Chemother, 2009,53 (7) : 2799-2803.

引证文献14

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部